As part of DTB’s “Don’t Drop Mixtard” campaign, this podcast discusses the implications of the drug’s withdrawal from the UK market for people with diabetes, healthcare professionals and the NHS.

The conversation involves Dr Wing May Kong (consultant endocrinologist and member of the DTB Editorial Board), Cathy Moulton (Care Adviser at Diabetes UK), and Dr Ike Iheanacho and David Phizackerley (Editor and Deputy Editor of DTB, respectively).

To find out more about the campaign, including DTB’s petition against the withdrawal of Mixtard 30, please go to dtb.bmj.com.

A monthly audio round-up detailing the contents of the latest issue of DTB.

Articles:
Mixtard 30 - going, going, gone?
Ulipristal – a new emergency contraceptive pill
Management of fibromyalgia
Agomelatine for major depressive episodes